ClinicalTrials.gg

Drug

PSMA-1007 F-18 clinical trials

studies test it
5
open now
2
in phase 3
2
first study started
2019

Keep track of what changes. Save the PSMA-1007 F-18 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

18F-PSMA-1007
3

Studies by the year they started

5 studies that test it; most in 2019 (2)

Studies that test PSMA-1007 F-18, by start year
YearStudies
20192
20221
20231
20241

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 3
2
No phase
2

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 1 · Other 4

Mayo Clinic (1) · ABX advanced biochemical compounds GmbH (1) · Affiliated Hospital of Jiangnan University (1) · University of Alberta (1) · First Hospital of China Medical University (1)

Often tested with

Tested in the same studies.

Gallium 68 PSMA-11 (1) · Fluorodeoxyglucose F18 (1)

Studies

Open first, then newest update. How each study uses PSMA-1007 F-18 is read from its arms, and is right about nine times in ten.

Testing it · 5

Codes

What other systems call PSMA-1007 F-18 · ClinicalTrials.gg INT016502

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.